STAT3 and cancer: The Janus kinase (JAK) and signal transducer and activator of transcription 3 (STAT3) signaling pathway is aberrantly hyperactivated in many types of cancer, and such hyperactivation is generally associated with a poor clinical prognosis [2,3].